Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. - Wikidata - awgldk - TriplyDB

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

http://www.wikidata.org/entity/Q37055208

about

Prospective application of clinician-performed lung ultrasonography during the 2009 H1N1 influenza A pandemic: distinguishing viral from bacterial pneumonia Current and future antiviral therapy of severe seasonal and avian influenza Influenza and the use of oseltamivir in children Modeling human influenza infection in the laboratory Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?Pandemic influenza: implications for preparation and delivery of critical care services What is the optimal therapy for patients with H5N1 influenza?Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong Kong Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China Estimating sensitivity of laboratory testing for influenza in Canada through modelling.Age-prioritized use of antivirals during an influenza pandemic.Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011 Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic.Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital.Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts.Statin treatment and mortality: propensity score-matched analyses of 2007-2008 and 2009-2010 laboratory-confirmed influenza hospitalizations.The Tie2-agonist Vasculotide rescues mice from influenza virus infection Demographic and clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in Central America and Dominican Republic 2009-2010.The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus.Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.2009 H1N1 influenza.Pandemic influenza A (H1N1) 2009: the experience of the first six months.Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection.Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza.Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China.Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009.Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data.Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.Novel swine--origin influenza A: the 2009 H1N1 influenza virus.Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China Correlates of severe disease in patients admitted with 2009 pandemic influenza A (H1N1) infection in Saurashtra region, India.Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.The need for strengthening the influenza virus detection ability of hospital clinical laboratories: an investigation of the 2009 pandemic.

P2860

Q22001351-64D10AD8-5CA4-42C2-B679-E3D7988583A6 Q24656164-8C41A038-1F22-4F67-9328-AD7583E25EFB Q26739661-F9954B53-DAB0-4548-B012-6A263DCF25FF Q26781842-32161A9D-F144-4D96-BD9C-9DE394EC05C0 Q26852067-C7FB4CDB-CA4E-4A9F-A23C-1F7BD6C5FA23 Q26852219-2788AF1F-57D5-4599-84A8-32989AC44F4D Q28390930-465486A2-3CFF-4895-AB69-35E18AA32418 Q28475630-7D628CDD-6C07-4CB6-A7CF-03373A3A8FFF Q28479036-DD04898C-A6E2-4E53-8CCC-A80DF0587D4A Q28684866-591E0908-3E3D-4A31-A00B-8AC8E31ABF56 Q28730856-6779F78E-6257-4530-991D-8E73AE62EBC6 Q28749090-A7EEBA9D-F69C-4D5A-A22C-BC17C7F7B3D1 Q30227634-84AA060E-E9A4-48E0-B1A9-E2CAF6FE256E Q30227718-DD8E110E-FB0D-4926-A048-ECC149EE2B03 Q30241087-8E89C347-3150-4B24-928B-C817B5FBE7B2 Q30353587-72BA6381-D1AC-48A4-8456-42EFA9199330 Q30357688-3F4537D4-8DC4-4C34-914F-0ABBA476CBE4 Q30358632-E490057D-B5ED-47CE-9764-0F186741DCF1 Q30368552-86A777C2-FF23-435B-93AA-D902AF7271CA Q30375212-FAEE6A3E-49DA-4B37-BAC2-035CA6C17E21 Q30375351-2BE756EC-AD1F-4D46-8B2E-01E679B76725 Q30377348-6D7A92D9-ED89-45CF-8073-7E0DAAD68446 Q30381548-F6F09949-D45C-4939-9118-F22E05CF783F Q30381799-64F3CD85-1BD3-4DBC-8D35-C42F8EA42469 Q30383437-FCCF8B8F-8936-4FCF-8AD7-6299EB11A9C6 Q30383709-7AF11676-898D-484B-B0F7-DC2A91E9304C Q30384722-62CE5A4E-7450-482B-B253-70ED346347DC Q30386485-1DDDE6F6-CAC8-4EA6-BB88-60270FDA42C8 Q30387832-9C05EAA6-4A5E-403E-8274-FEF318A38DD3 Q30388177-5EABB506-8AC1-4E67-8D32-74462C12CE40 Q30388312-1A8EAD30-20CE-4539-BA19-08B0F289476D Q30389844-8F1668CD-1912-4469-9277-EF406F9B6296 Q30391598-F89BB4BD-06FB-488B-8C5B-358436ED64F9 Q30392472-2BA2C0B5-D634-4792-89CB-D442017085A9 Q30394187-21C7A78B-8440-41A9-9E13-8FF59775C850 Q30394784-0D7B4B92-DAA8-4A43-B4FF-CBC3BBC408F3 Q30398438-5B6A69BB-DF94-41FA-BFE9-651030913901 Q30398797-47E5010F-7DB8-470D-8897-52BA86970147 Q30399530-5EF01B7C-5A62-49B9-BBFA-D8EEFCE87481 Q30399768-34C7EF63-ED21-44E7-909F-E8DCF906164E

P2860

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

http://www.wikidata.org/entity/Q37055208

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

@en

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

@nl

type

label

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

@en

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

@nl

prefLabel

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

@en

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

@nl

P1433

Q37055208-F4E3287D-5466-4ACD-B5D3-78ED4C0304C1

P1476

Q37055208-28BC27FC-F22B-492B-8C49-BCDE61580051

P2093

Q37055208-2795469C-0187-44FF-94A4-0F965E0CD3BA

Q37055208-2C8214CF-77AE-4605-BFDC-13540C2BCA55

Q37055208-40E69C4D-C4A2-4BD6-9D33-78203C6D6EC5

Q37055208-43474491-E63A-4192-9176-1BE1F288714F

Q37055208-63558B27-4A37-4DE0-9D4D-F53F80E4E939

Q37055208-AA5E60F3-A5DF-4F60-9B24-DCB6D6583CB0

P2860

Q37055208-061D0AEA-7016-4446-9CB1-5BDFBA21CA27

Q37055208-1AD02878-7651-42B3-A82E-33BE7E088AA3

Q37055208-2E82CAFC-54D4-44C3-BD5A-1AA960E78AA3

Q37055208-3BD1082D-B27E-473F-BBD2-EF3E2AD45239

Q37055208-453F8914-2CD8-4362-9B27-EEFA4DC25F17

Q37055208-4863712F-4DAA-4A0A-A395-2235C857AB36

Q37055208-56FA1283-B2DE-4395-845F-BD935E7666C1

Q37055208-61401398-A5CF-40A6-A447-8D5D183CB85F

Q37055208-6E28CEDD-088A-4346-B858-4B604A351056

Q37055208-7065135F-8D7E-4FD0-B740-BB84494A50BD

P304

Q37055208-B90D9E84-90AC-4FA6-933E-D8BE1B85F5D8

P31

Q37055208-BAD7CD04-9B91-48DE-9932-48F875583B10

P356

Q37055208-2101FF8D-5B76-43B4-AEDC-0307AE4AD405

P407

Q37055208-4E170BBD-15A6-4FAD-9408-7BA9B895CF02

P433

Q37055208-602A3927-38D8-42D6-9C0A-2D9597B59087

P478

Q37055208-D289EE14-1709-4483-BFF3-71B8AA7A21F9

P50

Q37055208-24F043C8-A37C-47B7-8BB5-CE817878FE29

Q37055208-7B478F54-1E48-43CE-875A-8AE421F56AC2

P577

Q37055208-54A2C1C5-1AE7-43B8-9DEB-B62412BFB562

P5875

Q37055208-3A613A3A-C24C-4C9E-AA9F-D3F9EBBF2741

P698

Q37055208-B8764746-3D2C-427E-A7A6-7E12B3CDBF82

P921

Q37055208-1B44037E-A641-41BC-BF84-11CAA345177F

Q37055208-4DD97372-0573-441F-97B3-D430187B8D51

P356

P1433

Clinical Infectious Diseases

P1476

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

@en

P2093

Agron Plevneshi

http://www.w3.org/2001/XMLSchema#string

Donald E Low

http://www.w3.org/2001/XMLSchema#string

Janet Raboud

http://www.w3.org/2001/XMLSchema#string

Karen A Green

http://www.w3.org/2001/XMLSchema#string

Nilofar Siddiqi

http://www.w3.org/2001/XMLSchema#string

Toronto Invasive Bacterial Diseases Network

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Mortality associated with influenza and respiratory syncytial virus in the United States

Influenza-associated hospitalizations in the United States

Influenza and the winter increase in mortality in the United States, 1959-1999.

Kinetics of influenza A virus infection in humans.

Clinical signs and symptoms predicting influenza infection.

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

Neuraminidase inhibitors for influenza.

Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

P304

1568-1575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/523584

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Altynay Shigayeva

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5661186

http://www.w3.org/2001/XMLSchema#string

P698

18190317

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization